In a recent study posted to the bioRxiv* preprint server, researchers examine the interactions between the influenza A virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a ...
Interview with Dr. Garth Rapeport on the development and implementation of a SARS-CoV-2 human challenge research program. 11m 18s Download Human challenge studies (also called controlled human ...
One of the key mutations seen in the 'Alpha variant' of SARS-CoV-2 - the deletion of two amino acids, H69/V70 - enables the virus to overcome chinks in its armour as it evolves, say an international ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged in France at the end of January 2020. Since then, SARS-CoV-2 has infected over 8.76 million French citizens and caused ...
Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533 Vaccine-induced nAbs are detectable at much lower rates ...
It’s that time of year: a thick, oppressive heat blankets everything, people huddle inside air-conditioned homes, offices, shops and cafes for respite—and COVID is surging again. Levels of SARS-CoV-2, ...
Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19. By mimicking the ...
In many ways, viruses are like families — giant, complicated, extended families with cousins, aunts, uncles, grannies and grandpas galore. Just as with human families, scientists can generate family ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback